SQLite Web: event_store.db

Update row 128779 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-18T03:05:05.644967+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:8e25661af395f767","evidence_event_ids":["evt_8dcca8929c7c"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","article_chars":1783,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_248f6ddd7c7a86f2","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:24:15.353837+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","source_event_id":"evt_8dcca8929c7c","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"5d337d37e1526d1d","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-18T03:05:05.644967+00:00","2025-12-18","2017-06-21","2026-06-21","1999-03-24"],"entities":[{"asset_class":"equity","name":"UNITED THERAPEUTICS Corp","relevance":"high","symbol":"UTHR","type":"issuer"},{"asset_class":"person","name":"Christopher Patusky","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"person","name":"John S. Hess, Jr.","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The cleaned text does not clearly label each Form 4 table row (e.g., whether each numeric line is shares acquired vs sold, and the exact share counts for each transaction) beyond the presence of Common Stock lines and the Rule 10b5-1 statement.","The signal indicates \"Filed 20260417\" but the provided structured context lists a filing_date of 2026-04-18T03:05:05.644967+00:00; the discrepancy is not explained in the text.","No explicit total shares bought/sold or total consideration amounts are clearly summarized in the provided excerpt beyond the individual numeric fields shown."],"key_facts":["SEC accession number: 0001231427-26-000001.","Form type: 4; filed as of date: 2026-04-17; conform ed period of report: 20260417.","Reporting owner: Christopher Patusky.","Issuer: United Therapeutics Corp (UTHR).","The filing includes Common Stock transactions dated 2026-04-17.","The filing text states: \"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025.\"","The filing includes a signature: \"/s/ John S. Hess, Jr. under Power of Attorney\" dated 2026-04-17."],"numeric_claims":[{"label":"Option exercise price (per share)","value":"101.80"},{"label":"Sale price (per share)","value":"101.80"},{"label":"Number of shares (exercise/sale line item shown)","value":"2490.00"},{"label":"Option exercise price (per share)","value":"578.88"},{"label":"Number of shares (exercise/sale line item shown)","value":"1490.00"},{"label":"Option exercise price (per share)","value":"2910.00"},{"label":"Option exercise date shown","value":"2017-06-21"},{"label":"Option expiration date shown","value":"2026-06-21"}],"primary_claim":"On 2026-04-17, United Therapeutics filed Form 4 reporting that Christopher Patusky exercised stock options and sold shares pursuant to a Rule 10b5-1 trading plan dated December 18, 2025.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"United Therapeutics (UTHR) filed a Form 4 on 2026-04-17 reporting transactions by reporting person Christopher Patusky. The filing states the activity relates to the exercise of stock options and subsequent sale of shares under a Rule 10b5-1 trading plan entered on 2025-12-18.","topics":["SEC Form 4","insider transaction","stock option exercise","Rule 10b5-1 trading plan","common stock sale"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260417","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel